All PVs observed within BRCA2 were deletion or duplication events which significantly disrupt gene function (c.3170_3174del, c.4787del, c.5557dup), these appeared only in cancer patients and high-risk patients, with 5 of 7 BRCA2 PV carriers affected. The gene discussed is BRCA2; the disease is cancer.